Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

APLS Apellis Pharmaceuticals Inc

41,28

-0,72 (-1,71%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Apellis Pharmaceuticals (NASDAQ:APLS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Apellis Pharmaceuticals Charts.

Apellis Pharmaceuticals (NASDAQ:APLS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Apellis Pharmaceuticals Charts.

News Apellis Pharmaceuticals Inc

Form 8-K - Current report
Dienstag 14 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street
Dienstag 14 Mai 2024 (4 Tage vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 8 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
Dienstag 7 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference
Montag 6 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Mittwoch 1 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
Freitag 26 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
Dienstag 23 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Donnerstag 4 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Montag 1 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Apellis Pharmaceuticals Inc News-Artikel

iShares High Yield Syste...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen